读取中,请稍候

00-00 00:00:00
--.--
0.00 (0.000%)
昨收盘:0.000今开盘:0.000最高价:0.000最低价:0.000
成交额:0成交量:0买入价:0.000卖出价:0.000
市盈率:0.000收益率:0.00052周最高:0.00052周最低:0.000
贝泰妮:2024年第一季度报告_英文版 下载公告
公告日期:2024-04-26

Stock Code: 300957 Stock Name: Botanee Announcement No.: 2024-012

Yunnan Botanee Bio-Technology Group Co., Ltd.

Quarterly Report 2024 Q1

The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate andcomplete without false record, misleading statement or major omission.Notices:

1. The Board of Directors and Board of Supervisors, as well as directors, supervisors and senior management of the Companyguarantee that the present quarterly report is true, accurate and complete without false record, misleading statement or majoromission, and undertake the joint and several legal liabilities.

2. Botanee’s legal representative Mr. Guo Zhenyu, CFO Mr. Wang Long, and Head of Accounting Department Mr. Liu Zhaofenghereby declare that the financial statements herein are true, accurate, and complete.

3. Whether Q1 report has been audited

□Yes ?No

I. Key Financial Data

(i) Major Accounting Data and Financial IndicatorsWhether the Company needs to retrospectively adjust or restate the accounting data for the previous years

□Yes ?No

This Reporting PeriodSame Period of the Previous YearChange in This Reporting Year over the Same Period of the Previous Year (%)
Operating revenue (CNY)1,096,940,645.49863,307,083.8027.06%
Net profit attributable to shareholders of the listed company (CNY)176,845,231.47158,265,044.3211.74%
Net profit attributable to shareholders of the listed company after deducting non-recurring profit or loss (CNY)154,346,690.47126,577,596.7121.94%
Net cash flows from operating activities (CNY)-157,714,269.99-196,770,597.6319.85%
Basic earnings per share (CNY/share)0.420.3713.51%
Diluted earnings per share (CNY/share)0.420.3713.51%
Weighted average return on net assets3.07%2.81%Increase 0.26pcts
End of This Reporting PeriodEnd of the Previous YearChange in the End of This Reporting Year over the End of the Previous Year (%)
Total assets7,060,400,018.287,506,930,342.79-5.95%
Net assets attributable to shareholders of the listed company (CNY)5,958,766,569.725,860,994,371.021.67%

Whether the Company’s share capital has changed and affected the amount of shareholders’ equity due to new issues, additionalissues, rights issues, stock ownership incentive exercise, buybacks and other reasons from the end of the reporting period to thedisclosure date of the quarterly report?Yes ?No

This Reporting Period
Dividends for Preferred Shares That Have Been Paid (CNY)
Interest Paid on Perpetual Bonds (CNY)
Fully Diluted Dividends per Share Based on Latest Share Capital (CNY/Share)0.4175

(ii) Item and Amount of Non-recurring Profit and Loss

? Applicable □ N/A

Unit: CNY

ItemAmount forDescription
This Reporting Period
Profit or loss from disposal of non-current assets (including the offset part of provisions for impairment of assets)3,159,516.70Profit or loss from disposal of non-current assets
Government subsidies included in the current profit or loss (excluding those closely related to the normal business of the Company, granted under the national policies and continuously enjoyed according to certain standards with lasting impacts on the Company’s profit and loss)6,081,973.96Government subsidies and incentives included in “other income” item
Except for the effective hedging activities related to the Company’s ordinary activities, profit or loss arising from changes in fair value of financial assets and financial liabilities held by non-financial enterprises, and profit or loss arising from from disposal of financial assets and financial liabilities12,444,776.07Profit or loss from changes in fair value of cash management projects handled by third parties with the Company’s authorization
Profits and losses on the assets by entrusting others to invest or manage10,720,698.39Income from mature investment in cash management projects handled by third parties with the Company’s authorization
Other non-operating income and expenses other than the above-5,751,517.93Mainly the donations for public welfare
Less: Effect on income tax4,012,913.49
Effect on minority interests (after-tax)143,992.70
Total22,498,541.00--

Other profit or loss conforming to the definition of non-recurring profit or loss

□ Applicable ? N/A

There is no other profit or loss conforming to the definition of non-recurring profit or loss

Explanation on defining the non-recurring profits and losses set out in the Explanatory Announcement No. 1 on InformationDisclosure for Companies Offering Securities to the Public - Non-Recurring Profit or Loss as recurring profits and losses

□ Applicable ? N/A

There is no non-recurring profits and losses set out in the Explanatory Announcement No. 1 on Information Disclosure forCompanies Offering Securities to the Public - Non-Recurring Profit or Loss as recurring profits and losses(iii) Changes in Major Accounting Data and Financial Indicators and Reasons

? Applicable □ N/A

1. Changes in the Items of Consolidated Balance Sheet at the End of the Reporting Period and Reasons

Unit: CNY

ItemBalance at the End of the Reporting PeriodBalance at the Beginning of the YearChangeProportion on Increase/ Decrease
Cash at bank and on hand1,343,444,241.122,091,459,861.58-748,015,620.46-35.77%
Financial assets held for trading1,610,799,112.411,238,356,707.34372,442,405.0730.08%
Notes receivable24,502,124.46-24,502,124.46-100.00%
Accounts receivable financing137,531,755.44156,659,263.78-19,127,508.34-12.21%
Prepayments142,355,751.1269,279,116.3873,076,634.74105.48%
Other receivables32,793,188.5729,748,433.093,044,755.4810.24%
Other current assets394,885,442.12446,396,252.76-51,510,810.64-11.54%
Projects under construction17,926,811.7040,220,147.41-22,293,335.71-55.43%
Right-of-use assets138,735,183.22100,712,614.9338,022,568.2937.75%
Deferred income tax assets105,499,904.4993,131,250.4512,368,654.0413.28%
Short-term loans169,222,593.55103,816,588.6065,406,004.9563.00%
Notes payable29,733,807.4667,562,710.23-37,828,902.77-55.99%
Accounts receivable112,449,307.13334,370,604.40-221,921,297.27-66.37%
Employee salary payable68,560,161.83106,452,763.55-37,892,601.72-35.60%
Tax payable72,434,971.41132,117,765.46-59,682,794.05-45.17%
Other payables176,049,497.02449,282,195.16-273,232,698.14-60.82%
Other current liabilities8,595,035.175,455,465.773,139,569.4057.55%
Long-term loans857,142.854,700,000.00-3,842,857.15-81.76%
Lease liabilities and non-current liabilities due within one year137,147,012.77105,385,826.6131,761,186.1630.14%
Treasury shares200,212,194.96109,838,205.8290,373,989.1482.28%

Reasons for Changes:

(1) The balance of monetary resources at the end of the reporting period stood at CNY1,343,444,200, a decrease of CNY748,015,600or about 35.77% compared with the beginning of the year. For changes in major cash flow of the Company’s monetary resourcesduring the reporting period, please refer to 3. Changes in Consolidated Statements of Cash Flow from the Beginning of the Year tothe End of the Reporting Period and Reasons of this Report.

(2) The total balance of trading financial assets at the end of the reporting period stood at CNY1,610,799,100, an increase ofCNY372,442,400 or about 30.08% compared with the beginning of the year, mainly due to the increased immature investmentbalance of cash management projects (managed by third parties with the Company’s authorization and measured at fair value) withavailable funds raised and its own funds within the quota authorized by the general meeting of shareholders at the end of thereporting period.

(3) There was no balance of notes receivable at the end of the reporting period, a significant decrease compared with the beginning ofthe year, mainly due to the mature commercial acceptance held by the Company during the reporting period and the full recovery ofrelevant receivables.

(4) The balance of receivables financing at the end of the reporting period stood at CNY137,531,800, a decrease of CNY19,127,500or about 12.21% compared with the beginning of the year, mainly due to the Company’s bill planning through various means such asacceptance at maturity, advance discount or endorsement transfer according to dynamic capital demands, and the decreased balanceof available bank acceptance at the end of the reporting period.

(5) The balance of prepayments at the end of the reporting period stood at CNY142,355,800, an increase of CNY73,076,600

compared with the beginning of the year or about 105.48%. The prepayments were mainly top-ups for promoting online stores onlarge B2C e-commerce platforms for marketing plans such as live streaming and advertising and production plans on the supplychain in the second quarter of 2024, marketing fees charged by marketing service providers and some core raw materials andmaterials purchased by OEM service providers. At the end of the reporting period, the Company had a big balance of prepayments,which was consistent with the Company’s production, marketing and sales models and cycles. The Company’s major expenses,major suppliers and the proportion of prepayments to total assets at the end of the first quarter of 2024 did not change significantlycompared with the end of the same period of the previous year. At the end of the reporting period, there were no associated parties ofthe Company among those who the Company had to make prepayments to. There was no fund misappropriation or illegal provisionof financial assistance by an associated party. At the end of the reporting period, the Company’s prepayment ratio within one yearwas about 99.01%. These prepayments are expected to be written off within the next 12 months.

(6) The balance of other receivables at the end of the reporting period stood at CNY32,793,200, an increase of CNY3,044,800 orabout 10.24% compared with the beginning of the year, mainly due to the increased rental deposit for logistics stores paid by theCompany during the reporting period.

(7) The balance of other liquid assets at the end of the reporting period stood at CNY394,885,400, a decrease of CNY51,510,800 orabout 11.54% compared with the beginning of the year, mainly due to the decrease in the Company’s outstanding VAT credits andVAT reductions to be verified and deducted at the end of the reporting period.

(8) The balance of projects under construction at the end of the reporting period stood at CNY17,926,800, a decrease ofCNY22,293,300 or about 55.43% compared with the beginning of the year, mainly due to the transfer of the freeze-dried maskproduction line project of the new base of the Company’s central factory to fixed assets after passing the check for acceptance duringthe reporting period. This project only uses the Company’s own funds and will increase the Company’s self-production capacity ofpatch masks after being put into production.

(9) The balance of the right-of-use assets at the end of the reporting period stood at CNY138,735,200, an increase of CNY38,022,600or about 37.75% compared with the beginning of the year, mainly due to the increase in the Company’s current lease contracts forbusiness premises during the reporting period. These business premises rented by the Company were mainly for production, R&D,storage and office purposes at the end of the reporting period.

(10) The balance of deferred income tax assets at the end of the reporting period stood at CNY105,499,900, an increase ofCNY12,368,700 or about 13.28% compared with the beginning of the year, mainly due to the increased deductible temporarydifferences in the Company’s lease liabilities, equity incentive expenses and deductible losses at the end of the reporting period.

(11) The balance of short-term loans at the end of the reporting period stood at CNY169,222,600, an increase of CNY65,406,000 orabout 63.00% compared with the beginning of the year, mainly due to a big increase in short-term financial loans for liquid capitalissued by commercial banks during the reporting period.

(12) The balance of notes payable at the end of the reporting period stood at CNY29,733,800, a decrease of CNY37,828,900 or about

55.99% compared with the beginning of the year, mainly due to the decrease in the remaining immature bank acceptance payable atthe end of the reporting period. At the end of the reporting period, the Company had no notes payable due or unaccepted.

(13) The balance of accounts payable at the end of the reporting period stood at CNY112,449,300, a decrease of CNY221,921,300 orabout 66.37% compared with the beginning of the year, mainly due to the Company’s payments for production materials and

productive services as scheduled. During the reporting period, the Company had no overdue payments due to suppliers.

(14) The balance of salary payable to employees at the end of the reporting period stood at CNY68,560,200, a decrease ofCNY37,892,600 or about 35.60% compared with the beginning of the year, mainly due to the Company’s payment for the year-endone-time bonus to employees for the year 2023 during the reporting period.

(15) The balance of taxes payable at the end of the reporting period stood at CNY72,435,000, a decrease of CNY59,682,800 or about

45.17% compared with the beginning of the year, mainly due to the Company’s payment for various taxes payable preliminarilycalculated by the Company at the beginning of the reporting period.

(16) The balance of other payables at the end of the reporting period stood at CNY176,049,500, a decrease of CNY273,232,700 orabout 60.82% compared with the beginning of the year, mainly due to the Company’s payment for the marketing fees charged bylarge B2C e-commerce platforms and other marketing service providers accrued in the fourth quarter of 2023, and for engineeringequipment for the new base of the central factory and other engineering projects as scheduled, and shorter cycles of other balancespayable. At the end of the reporting period, the Company’s other balances payable were small, consistent with the Company’smarketing and sales models and cycles. The Company’s major expenses, major suppliers and the proportion of other payables to totalassets at the end of the first quarter of 2024 did not change significantly compared with the end of the same period of the previousyear. At the end of the reporting period, there were no associated parties of the Company among those who the Company had tomake prepayments to. There was no fund misappropriation or illegal provision of financial assistance by an associated party.

(17) The balance of other liquid liabilities at the end of the reporting period stood at CNY8,595,000, an increase of CNY3,139,600 orabout 57.55% compared with the beginning of the year, mainly due to the increased balance of returns payable accrued by theCompany at the end of the reporting period.

(18) The balance of long-term loans at the end of the reporting period stood at CNY857,100, a decrease of CNY3,842,900 comparedwith the beginning of the year. This big decrease was mainly due to the Company’s repayment of the principal of long-term financialloans from commercial banks at the end of the reporting period according to dynamic capital demands.

(19) The total balance of lease liabilities and non-liquid liabilities due within one year at the end of the reporting period stood atCNY137,147,000, an increase of CNY31,761,200 or about 30.14% compared with the beginning of the year, mainly due to theincrease in the Company’s current lease contracts for business premises at the end of the reporting period. These business premisesrented by the Company were mainly for production, R&D, storage and office purposes at the end of the reporting period. The totalbalance of lease liabilities and non-liquid liabilities due within one year at the end of the reporting period was basically consistentwith the changes in the balance of right-of-use assets at the end of the reporting period.

(20) The balance of treasury shares at the end of the reporting period stood at CNY200,212,200, an increase of CNY90,374,000 orabout 82.28% compared with the beginning of the year, mainly due to the increase in the Company’s ordinary shares repurchasedwith its own funds through call auction in accordance with the resolution of the Board of Directors during the reporting period. Fordetails, please refer to the Announcement by Yunnan Botanee Bio-Technology Group Co., Ltd. on the Progress of Share Repurchase(2024-009) disclosed on cninfo’s website (http://www.cninfo.com.cn).。

2. Changes in the Items of Consolidated Income Statement from the Beginning of the Year to the End ofthe Reporting Period and Reasons

Unit: CNY

ItemCurrent AmountAmount Incurred in the Same Period of the Previous YearChangeProportion on Increase/ Decrease
Operating revenue1,096,940,645.49863,307,083.80233,633,561.6927.06%
Operating costs306,201,911.22206,280,038.1399,921,873.0948.44%
Tax and additional tax8,603,141.177,790,149.34812,991.8310.44%
Marketing expenses512,649,843.99410,938,284.12101,711,559.8724.75%
Administration expenses75,651,161.2166,631,543.709,019,617.5113.54%
Other incomes7,985,377.364,825,935.943,159,441.4265.47%
Investment income10,575,655.895,688,720.314,886,935.5885.91%
Income from changes in fair value12,444,776.0731,451,953.37-19,007,177.30-60.43%
Losses from credit impairment (losses are marked with “-”)-752,582.03-2,738,672.931,986,090.9072.52%
Losses from asset impairment(losses are marked with “-”)1,521,923.22-4,313,168.815,835,092.03135.29%
Asset disposal income3,159,516.70718,876.652,440,640.05339.51%
Income tax22,507,593.2918,954,031.763,553,561.5318.75%

Reasons for Changes:

(1) The Company’s operating revenue from the beginning of the year to the end of the reporting period stood at CNY1,096,940,600,an increase of CNY233,633,600 or about 27.06% compared with the same period of the previous year, mainly due to the furtherimprovement of the Company’s products and brand awareness from the beginning of the year to the end of the reporting period,which led to bigger sales scale and higher sales revenue. These figures included the sales revenue of Za and PURE&MILD, whichthe Company successfully acquired on October 31, 2023. Taking into consideration only the brands included during the last reportingperiod, the Company’s operating revenue stood at about CNY959,395,100 from the beginning of the year to the end of the reportingperiod, an increase of about 11.13%.

(2) The Company’s operating costs from the beginning of the year to the end of the reporting period stood at CNY306,201,900, anincrease of CNY99,921,900 or about 48.44% compared with the same period of the previous year, mainly due to the increasedoperating costs as the Company’s sales scale and sales revenue rose. These figures included the marketing costs of Za andPURE&MILD, which the Company successfully acquired on October 31, 2023. Taking into consideration only the brands includedduring the last reporting period, the Company’s operating costs stood at about CNY247,494,900 from the beginning of the year to theend of the reporting period, an increase of about 19.98%. The gross profit margin on sales was about 74.20%. The growth of theCompany’s operating costs basically matched the growth of the sales scale, and the production costs were basically stable. From thebeginning of the year to the end of the reporting period, the growth rate of operating costs was slightly higher than that of operatingrevenue, mainly due to the dynamic adjustments of the Company’s promotion policies and product portfolios according to the market.

(3) The Company’s tax and additional tax from the beginning of the year to the end of the reporting period stood at CNY8,603,100,an increase of CNY813,000 or about 10.44% compared with the same period of the previous year, mainly due to the increased taxand additional tax as the Company’s sales scale and sales revenue rose. The growth rate of the Company’s tax and additional taxfrom the beginning of the year to the end of the reporting period was lower than that of the sales revenue, mainly due to the decreased

input VAT plus tax credits and the decreased taxable sales revenue for consumption tax during the reporting period.

(4) The Company’s marketing expenses from the beginning of the year to the end of the reporting period stood at CNY512,649,800,an increase of CNY101,711,600 or about 24.75% compared with the same period of the previous year, mainly due to thecontinuously increased investment in brand image promotion and communication, human resources and storage as the Company’ssales scale and sales revenue rose. The growth of the Company’s marketing expenses basically matched that of the sales scale.

(5) The Company’s administration expenses from the beginning of the year to the end of the reporting period stood atCNY75,651,200, an increase of CNY9,019,600 or about 13.54% compared with the same period of the previous year, mainly due tothe increased salary of managerial staff, equity incentive costs and other administrative expenses as the Company scaled up. Thegrowth rate of the Company’s administration expenses from the beginning of the year to the end of the reporting period was lowerthan that of the sales scale, mainly due to the effective cost reduction and efficiency improvement measures for administrativefunctions and back-stage management expenses implemented by the Company during the reporting period.

(6) The Company’s other incomes from the beginning of the year to the end of the reporting period stood at CNY7,985,400, anincrease of CNY3,159,400 or about 65.47% compared with the same period of the previous year, mainly due to the increased taxcredits of input VAT and the increased revenue-related government subsidies for the Company compared with the same period ofthe previous year from the beginning of the year to the end of the reporting period.

(7) The Company’s investment income from the beginning of the year to the end of the reporting period stood at CNY10,575,700,an increase of CNY4,886,900 or about 85.91% compared with the same period of the previous year. This big increase was mainlydue to the increased maturity yield generated by the Company’s cash management projects (managed by third parties with theCompany’s authorization and measured at fair value) from the beginning of the year to the end of the reporting period.

(8) The Company’s net income from changes in fair value from the beginning of the year to the end of the reporting period stoodat CNY12,444,800, a decrease of CNY19,007,200 or about 60.43% compared with the same period of the previous year, mainlydue to the decreased fair value fluctuations of the cash management projects (managed by third parties with the Company’sauthorization and measured at fair value) compared with the same period of the previous year during the reporting period.

(9) The Company’s net losses from credit impairment from the beginning of the year to the end of the reporting period stood atCNY752,600, a decrease of CNY1,986,100 compared with the same period of the previous year. This big decrease was mainly dueto the decreased provision for receivables impairment during the reporting period. During the reporting period, there were nochanges in the Company’s accounting policies and accounting estimates for the provision for receivables impairment.

(10) The Company’s net income from asset impairment from the beginning of the year to the end of the reporting period stood atCNY1,521,900, mainly due to the net write-back of the Company’s provision for inventory impairment. During the reportingperiod, there were no changes in the Company’s accounting policies and accounting estimates for the provision for inventoryimpairment.

(11) The Company’s asset disposal income from the beginning of the year to the end of the reporting period stood atCNY3,159,500, an increase of CNY2,440,600 compared with the same period of the previous year. This big year-on-year increasewas mainly due to the early termination of lease contracts and the cancellation of right-of-use assets during the reporting period.

(12) The Company’s income tax from the beginning of the year to the end of the reporting period stood at CNY22,507,600, anincrease of CNY3,553,600 or about 18.75% compared with the same period of the previous year, mainly due to the increasedcorporate income tax as the sales scale and total profits increased.

3. Changes in the Items of Consolidated Statement of Cash Flow from the Beginning of the Year to theEnd of the Reporting Period and Reasons

Unit: CNY

ItemCurrent AmountAmount Incurred in the Same Period of the Previous YearChangeProportion on Increase/ Decrease

Cash inflow frombusiness operations

Cash inflow from business operations1,289,100,731.71956,511,167.50332,589,564.2134.77%
Cash outflow to business operations1,446,815,001.701,153,281,765.13293,533,236.5725.45%
Cash inflow from investment activities681,304,135.991,062,386,090.04-381,081,954.05-35.87%

Cash outflow toinvestment activities

Cash outflow to investment activities1,112,435,766.791,679,824,366.87-567,388,600.08-33.78%
Cash inflow from financing activities69,222,593.5569,222,593.55
Cash outflow to financing activities225,881,999.0921,609,005.20204,272,993.89945.31%

Reasons for Changes:

(1) The Company’s cash inflow from business operations from the beginning of the year to the end of the reporting period stood atCNY1,289,100,700, an increase of CNY332,589,600 or about 34.77% compared with the same period of the previous year, mainlydue to the increased cash inflow brought by the rapid growth of the Company’s sales scale and sales revenue. From the beginningof the year to the end of the reporting period, the growth of cash inflow from business operations basically matched that of thesales scale.

(2) The Company’s cash outflow to business operations from the beginning of the year to the end of the reporting period stood atCNY1,446,815,000, an increase of CNY293,533,200 or about 25.45% compared with the same period of the previous year, mainlydue to the increase in other operating expenses incurred by brand image promotion and communication, human resources and e-commerce platforms. From the beginning of the year to the end of the reporting period, the growth of cash outflow to businessoperations basically matched that of the sales scale.

(3) The Company’s cash inflow from investment activities from the beginning of the year to the end of the reporting period stoodat CNY681,304,100, a decrease of CNY381,082,000 or about 35.87% compared with the same period of the previous year, mainlydue to the immaturity of major cash management projects managed by third parties with the Company’s authorization at the end ofthe reporting period.

(4) The Company’s cash outflow to investment activities from the beginning of the year to the end of the reporting period stood atCNY1,112,435,800, a decrease of CNY567,388,600 or about 33.78% compared with the same period of the previous year, mainlydue to the immaturity of major cash management projects managed by third parties with the Company’s authorization and

decreased investment in cash management projects with available funds raised and its own funds within the smaller quotaauthorized by the general meeting of shareholders from the beginning of the year to the end of the reporting period.

(5) The Company’s cash inflow from financing activities from the beginning of the year to the end of the reporting period stood atCNY69,222,600, mainly due to the cash of short-term financial loans received from commercial banks for liquid capital during thereporting period.

(6) The Company’s cash outflow to financing activities from the beginning of the year to the end of the reporting period stood atCNY225,882,000, an increase of CNY204,273,000 compared with the same period of the previous year, mainly because theCompany repurchased its ordinary shares with its own funds through call auction according to the resolution of the Board ofDirectors and repaid the principal and interest of long-term and short-term financial loans to commercial banks according todynamic capital demands.

II. Shareholder Information(i) Total Number of Ordinary Shareholders and the Number of Preferred Shareholders Whose VotingRights Have Been Restored and Shareholding of Top 10 Shareholders

Unit: Share

Total number of ordinary share shareholder s as of the end of the reporting period34,356Total number of preferred shareholders (if any) resuming voting rights at the end of the reporting period
Shareholdings of top 10 shareholders (excluding shares lent through conversions)
Shareholder NameNatureShareholding proportion(%)Number of shares heldNumber of shares subject to trading restriction heldPledged, marked or frozen shares
Status of sharesQuantity
Kunming Nuona Technology Co., Ltd.Domestic non-state-owned corporate46.08%195,212,611.00Not Applicable
Tianjin Sequoia Juye Equity Investment Partnership (Limited Partnership)Domestic non-state-owned corporate14.58%61,763,257.00Not Applicable
Xiamen Zhenli Consulting Co., Ltd.Domestic non-state-owned corporate6.54%27,685,934.00Not Applicable
Hong Kong Securities Clearing Company LimitedOverseas legal person3.28%13,886,556.00Not Applicable
Yunnan Haqisheng Enterprise Management Co., Ltd.Domestic non-state-owned corporate2.60%10,993,678.00Not Applicable
Xiamen Chonglou Yunshui Investment Partnership (Limited Partnership)Domestic non-state-owned corporate1.30%5,526,929.00Not Applicable
Kuwait Investment AuthorityOverseas legal person1.25%5,285,437.00Not Applicable
National Social Security Fund 102 PortfolioMiscellaneous0.66%2,816,813.00Not Applicable
Industrial and Commercial Bank of China Limited - Efund GEM Exchange-traded Open Index Securities Investment FundMiscellaneous0.57%2,433,281.00Not Applicable
National Social Security Fund 504 PortfolioMiscellaneous0.47%1,992,075.00Not Applicable
Shareholdings of top ten shareholders without trading limited condition
ShareholderNumber of shares not subject to trading restriction as at the end of reporting periodTypes of shares
Types of sharesQuantity
Kunming Nuona Technology Co., Ltd.195,212,611.00CNY common shares195,212,611.00
Tianjin Sequoia Juye Equity Investment Partnership (Limited Partnership)61,763,257.00CNY common shares61,763,257.00
Xiamen Zhenli Consulting Co., Ltd.27,685,934.00CNY common shares27,685,934.00
Hong Kong Securities Clearing Company Limited13,886,556.00CNY common shares13,886,556.00
Yunnan Haqisheng Enterprise Management Co., Ltd.10,993,678.00CNY common shares10,993,678.00
Xiamen Chonglou Yunshui Investment Partnership (Limited Partnership)5,526,929.00CNY common shares5,526,929.00
Kuwait Investment Authority5,285,437.00CNY common shares5,285,437.00
National Social Security Fund 102 Portfolio2,816,813.00CNY common shares2,816,813.00
Industrial and Commercial Bank of China Limited - Efund GEM Exchange-traded Open Index Securities Investment Fund2,433,281.00CNY common shares2,433,281.00
National Social Security Fund 504 Portfolio1,992,075.00CNY common shares1,992,075.00
Description on the related relationship or concerted action among the above shareholdersKunming Nuona Technology Co., Ltd. and Yunnan Haqisheng Enterprise Management Co., Ltd. are both controlled by Guo Zhenyu and KEVIN GUO (father and son), the actual controllers of the Company. Except this, the Company does not know whether other shareholders have an association or a concerted action relationship.
Description of top 10 shareholders participating in securities margin trading (if any)Not applicable.

Note: As of March 31, 2024, the number of shares held under the unlimited sale condition in the buyback special securitiesaccount of Yunnan Botanee Bio-Technology Group Co., Ltd. was 2,994,618 shares, accounting for approximately 0.71% of theCompany’s issued CNY ordinary shares at the end of the reporting period.

Securities financing and share lending of shareholders holding more than 5%, top 10 shareholders and top 10 shareholders ofunlimited tradable shares

□Applicable ?Not Applicable

Changes over the previous period because top 10 shareholders and the top 10 shareholders holding shares not subject to tradingrestriction lend/return securities financing

□Applicable ?Not Applicable

(ii) Total number of preferred shareholders and top 10 preferred shareholders of the Company

□Applicable ?Not Applicable

(III) Changes in Restricted Shares?Applicable ?Not Applicable

Unit: Share

Shareholder NameNumber of restricted shares as at the beginning of the periodTermination in the current period Number of restricted sharesIncrease in the current period Number of restricted sharesNumber of Restricted shares as at the end of the periodReasons for trading restrictionRelease date of restriction
Kunming Nuona Technology Co., Ltd.195,212,611.00195,212,611.00Shares before initial public offeringsMarch 25, 2024
Yunnan Haqisheng Enterprise Management Co., Ltd.10,993,678.0010,993,678.00Shares before initial public offeringsMarch 25, 2024
Total206,206,289.00206,206,289.00

Note: For details, please refer to the Indicative Announcement on the Circulation of Some Issued Shares of Yunnan Botanee Bio-Technology Group Co., Ltd. (2024-008) before IPO on cninfo’s website (http://www.cninfo.com.cn).

III. Other Important Matters

□Applicable ?Not Applicable

IV. Quarterly Financial Statement(i) Financial Statement

1. Consolidated Balance Sheet

Prepared by: Yunnan Botanee Bio-Technology Group Co., Ltd.

March 31, 2024

Unit: CNY

ItemBalance at the End of the Reporting PeriodBalance at the Beginning of the Reporting Period
Current assets:
Cash at bank and on hand1,343,444,241.122,091,459,861.58
Settlement reserves
Loans to banks and other financial institutions
Financial assets held for trading1,610,799,112.411,238,356,707.34
Derivative financial assets
Notes receivable24,502,124.46
Accounts receivable512,174,991.94561,761,929.57
Receivables financing137,531,755.44156,659,263.78
Advances to suppliers142,355,751.1269,279,116.38
Premiums receivable
Reinsurance premium receivable
Reinsurance contract reserves receivable
Other accounts receivable32,793,188.5729,748,433.09
Including: interest receivable
Dividends receivable
Financial assets purchased under agreement store sell
Inventories830,566,558.90904,413,283.67
Including: data resources
Contract assets
Held-for-sale assets
Current portion of non-current assets
Other current assets394,885,442.12446,396,252.76
Total current assets5,004,551,041.625,522,576,972.63
Non-current assets:
Disbursement of loans and advances to customers
Debt investment
Other debt investment
Long-term receivables
Long-term equity investment218,370,108.65212,015,151.15
Investment in other equity instruments
Other non-current financial assets91,449,823.0086,449,823.00
Investment real estates8,702,323.269,021,481.56
Fixed assets686,030,584.71667,204,436.83
Projects under construction17,926,811.7040,220,147.41
Productive biological assets
Oil and gas assets
Right-of-use assets138,735,183.22100,712,614.93
Intangible assets199,099,505.63193,108,638.64
Including: data resources
Development expenditures
Including: data resources
Goodwill413,740,760.61413,740,760.61
Long-term deferred expenses93,306,043.7193,317,644.84
Deferred income tax assets105,499,904.4993,131,250.45
Other non-current assets82,987,927.6875,431,420.74
Total non-current assets2,055,848,976.661,984,353,370.16
Total assets7,060,400,018.287,506,930,342.79
Current liabilities:
Short-term borrowings169,222,593.55103,816,588.60
Borrowings from the central bank
Placements from banks and other financial institutions
Financial liabilities held for trading
Derivative financial liabilities
Notes payable29,733,807.4667,562,710.23
Accounts payable112,449,307.13334,370,604.40
Advances from customers
Contract liabilities50,698,653.6050,053,638.68
Financial assets sold under agreements to repurchase
Customer bank deposits and due to banks and other financial institutions
Customer brokerage deposits
Securities underwriting brokerage deposits
Employee compensation payable68,560,161.83106,452,763.55
Taxes payable72,434,971.41132,117,765.46
Other payables176,049,497.02449,282,195.16
Including: interests payable69,661.77
Dividends payable4,305.04
Handling charges and commission payable
Reinsurance premium payable
Held-for-sale liabilities
Non-current liabilities due within one year55,891,140.0242,102,294.00
Other current liabilities8,595,035.175,455,465.77
Total current liabilities743,635,167.191,291,214,025.85
Non-current liabilities:
Insurance contract reserves
Long-term borrowings857,142.854,700,000.00
Bonds payable
Including: Preferred shares
Perpetual bonds
Lease liabilities81,255,872.7563,283,532.61
Long-term payables8,600,000.008,600,000.00
Long-term employee benefits payable
Estimated liabilities
Deferred income77,500,127.9682,862,738.40
Deferred tax liabilities39,370,161.0840,452,457.50
Other non-current liabilities
Total non-current liabilities207,583,304.64199,898,728.51
Total liabilities951,218,471.831,491,112,754.36
Owners' equity:
Share capital423,600,000.00423,600,000.00
Other equity instruments
Including: Preferred shares
Perpetual bonds
Capital reserves2,859,970,626.922,846,004,685.04
Less: treasury shares200,212,194.96109,838,205.82
Other comprehensive incomes-1,101,763.2547,153.49
Special reserves
Surplus reserve211,081,299.10211,081,299.10
General risk provision
Undistributed profit2,665,428,601.912,490,099,439.21
Total owners' equity attributable to the parent company5,958,766,569.725,860,994,371.02
Minority interest150,414,976.73154,823,217.41
Total owners' equity6,109,181,546.456,015,817,588.43
Total liabilities and owners' equity7,060,400,018.287,506,930,342.79

Legal representative: Guo Zhenyu

CFO: Wang Long

Head of Accounting Department: LiuZhaofeng

2. Consolidated Income Statement

Unit: CNY

ItemAmount of the Reporting PeriodAmount of Precious Reporting Period
I. Total operating revenue1,096,940,645.49863,307,083.80
Including: Operating revenue1,096,940,645.49863,307,083.80
Interest income
Earned premiums
Handling charges and commission income
II. Total operating cost931,179,210.70718,760,135.76
Including: operating costs306,201,911.22206,280,038.13
Interest expenses
Handling charges and commission expenses
Surrender value
Net payments for insurance claims
Net provision for insurance contract reserves
Policy dividend expenses
Reinsurance expenses
Taxes and surcharges8,603,141.177,790,149.34
Selling expenses512,649,843.99410,938,284.12
Management expenses75,651,161.2166,631,543.70
R&D expenses32,646,832.9633,955,217.71
Financial expenses-4,573,679.85-6,835,097.24
Including: interest expenses2,770,460.671,098,960.38
Interest income-7,594,888.61-8,274,640.69
Add: other incomes7,985,377.364,825,935.94
Investment income (loss to be listed with “-”)10,575,655.895,688,720.31
Including: income from investment in associates and joint ventures-145,042.50
Revenue from derecognition of financial assets at amortized cost5,058,786.22
Exchange earnings (losses to be listed with “-”)
Net exposure hedging income (loss to be listed with “-”)
Profit arising from changes in fair value (loss expressed with "- ")12,444,776.0731,451,953.37
Credit impairment losses (losses to be listed with “-”)-752,582.03-2,738,672.93
Asset impairment loss (loss to be listed with "-")1,521,923.22-4,313,168.81
Incomes of assets disposal (losses to be listed with “-”)3,159,516.70718,876.65
III. Operating profit (loss to be listed with "-")200,696,102.00180,180,592.57
Add: non-operating revenue268,588.39400,768.55
Less: Non-operating expenses6,020,106.326,612,043.18
IV. Total profit (total loss to be listed with "-")194,944,584.07173,969,317.94
Less: income tax expenses22,507,593.2918,954,031.76
V. Net profit (net loss to be listed with "-")172,436,990.78155,015,286.18
(I) Classified by going concern
1. Net profit from continuing operations (net loss to be listed with “-”)172,436,990.78155,015,286.18
2. Net profit from discontinued operations (net loss to be listed with "-")
(II) Classified by attribution of ownership
1.Net profit attributable to the parent company's shareholders176,845,231.47158,265,044.32
2. Non-controlling interests-4,408,240.69-3,249,758.14
VI. Net of tax of other comprehensive income-1,148,916.74
Other net after-tax comprehensive income attributable to the owners of the parent company-1,195,875.08
(I) Other comprehensive income that cannot be reclassified through profit or loss
1. Changes arising from re-measurement of the defined benefit plan
2. Other comprehensive incomes that cannot be reclassified into profit or loss under the equity method
3. Changes in fair value of other equity instrument investments
4. Changes in fair value of the Company’s credit risk
5. Others
(II) Other comprehensive income to be reclassified into profit or loss-1,195,875.08
1. Other comprehensive income that can be reclassified into profit or loss under the equity method
2. Changes in fair value of other creditor's rights investments
3. Amount of financial assets reclassified into other comprehensive incomes
4. Provision for impairment of credit in other debt investments
5. Reserves for cash flow hedge
6. Translation difference arising from foreign currency financial statements-1,195,875.08
7. Others
Other net after-tax comprehensive income attributable to minority shareholders46,958.34
VII. Total comprehensive income171,288,074.04155,015,286.18
Total comprehensive income attributable to the owners of the parent company175,649,356.39158,265,044.32
Total comprehensive income attributable to minority shareholders-4,361,282.35-3,249,758.14
VIII. Earnings per share
(I) Basic earnings per share0.420.37
(II) Diluted earnings per share0.420.37

In case of business combinations under common control in current period, the net profit realized by the combined party beforecombination is CNY 0.00 and the net profit realized by the combined party in previous period is CNY 0.00.

Legal representative: Guo Zhenyu

CFO: Wang Long

Head ofAccountingDepartment: LiuZhaofeng

3. Consolidated Cash Flow Statement

Unit: CNY

ItemAmount of the Reporting PeriodAmount of Precious Reporting Period
I. Cash flows from operating activities:
Cash received from sales of goods or rendering of services1,275,917,110.75944,703,091.31
Net increase in deposits from customers and placements from banks and other financial institutions
Net increase in borrowings from the central bank
Net increase in placements from other financial institutions
Cash received for receiving premium of original insurance contract
Net cash received from reinsurance business
Net increase in deposits of the insured and investment
Cash received from interest, handling charges and commission
Net increase in placements from banks and other financial institutions
Net increase in capital for repurchase
Net cash received from securities trading agency services
Taxes and surcharges refunds1,585,654.76
Other cash received relating to operating activities13,183,620.9610,222,421.43
Subtotal of cash inflows from operating activities1,289,100,731.71956,511,167.50
Cash paid for goods and services379,949,715.47336,605,023.22
Net increase in loans and advances to customers
Net increase in deposits in the central bank and other financial institutions
Cash paid for claim settlements on original insurance contract
Net increase in placements from banks and other financial institutions
Cash paid for interest, handling charges and commission
Cash paid for policy dividends
Cash paid to and for employees235,214,505.18202,534,843.45
Payments of taxes and surcharges127,754,843.63116,290,752.97
Other cash paid relating to operating activities703,895,937.42497,851,145.49
Subtotal of cash outflows from operating activities1,446,815,001.701,153,281,765.13
Net cash flow from operating activities-157,714,269.99-196,770,597.63
II. Cash flows from investing activities:
Cash received from the return of investment670,000,000.001,049,617,111.10
Cash received from investment incomes11,304,135.9910,059,178.94
Net cash received from the disposal of fixed assets, intangible assets, and other long-term assets2,709,800.00
Net cash received from the disposal of subsidiaries and other business entities
Other cash received relating to investing activities
Subtotal of cash inflows from investing activities681,304,135.991,062,386,090.04
Cash paid to acquire fixed assets, intangible assets and other long- term assets70,935,766.7937,406,207.05
Cash paid to acquired investments1,041,500,000.001,641,416,055.23
Net increase in pledge loans
Net cash paid for acquisition of subsidiaries and other business entities1,002,104.59
Other cash paid relating to investment activities
Subtotal of cash outflows from investing activities1,112,435,766.791,679,824,366.87
Net cash flows from investing activities-431,131,630.80-617,438,276.83
III. Cash flows from financing activities:
Cash received from absorbing investments
Including: Cash received by subsidiaries from minority shareholders'investments
Cash received from borrowings69,222,593.55
Cash received relating to other financing activities
Subtotal of cash inflows from financing activities69,222,593.55
Cash paid for repayment of debts107,642,857.15
Cash paid for distribution of dividends, profits or interest repayment2,491,963.961,520,824.84
Including: cash payments for dividends or profit to minority shareholders of subsidiaries1,217,455.371,520,824.84
Other cash paid relating to financing activities115,747,177.9820,088,180.36
Subtotal of cash outflows from financing activities225,881,999.0921,609,005.20
Net cash flows from financing activities-156,659,405.54-21,609,005.20
IV. Effects from the change of exchange rate on cash and cash equivalents-942,902.91-394.71
V. Net increase in cash and cash equivalents-746,448,209.24-835,818,274.37
Add: Opening balance of cash and cash equivalents2,073,881,743.782,440,692,701.42
VI. Closing balance of cash and cash equivalents1,327,433,534.541,604,874,427.05

Legal representative: Guo Zhenyu

CFO: Wang Long

Head of Accounting Department: LiuZhaofeng

(II) Information about Adjusting Related Items in Financial Statements for the Year atthe Beginning of the Year According to New Accounting Standards Since 2024

?Applicable ?N/AFor details, please refer to the Announcement by Yunnan Botanee Bio-Technology Group Co., Ltd. on Changes in AccountingPolicies on cninfo’s website (http://www.cninfo.com.cn)

(iii) Audit Report

Whether the Q1 report has been audited

□Yes ?No

The Q1 report of the Company has not been audited

Board of Directors of Yunnan Botanee Bio-Technology Group Co., Ltd.

April 24, 2024


  附件:公告原文
返回页顶